TABLE 4.
Multivariable Survival Analysis of Laser Trabeculoplasty Outcomes
| Parameters | Hazard Ratio | 95% Hazard Ratio Confidence Limits | P | Comments | |
|---|---|---|---|---|---|
| Age (y) | |||||
| 18-39 | 1.37 | 1.22 | 1.53 | <0.0001* | Age: per patient eye, 5 levels: 18-39, 40-64, 65-79 (reference), 80+ |
| 40-64 | 0.96 | 0.93 | 1.00 | 0.0738 | |
| 80+ | 1.44 | 1.39 | 1.49 | <0.0001* | |
| Unknown | 1.60 | 1.33 | 1.93 | <0.0001* | |
| Sex | |||||
| Female | 0.93 | 0.90 | 0.95 | <0.0001* | Sex: per patient, 3 levels: male (reference), female, unspecified |
| Unspecified | 1.19 | 0.93 | 1.48 | 0.1345 | |
| Region | |||||
| Midwest | 0.92 | 0.89 | 0.95 | <0.0001* | Region: per patient eye, provider region, 5 levels: Midwest, Northeast, West, South (reference), unknown |
| Northeast | 0.91 | 0.88 | 0.95 | <0.0001* | |
| West | 0.94 | 0.90 | 0.98 | 0.0046* | |
| Unknown | 1.22 | 1.05 | 1.42 | 0.0103* | |
| Race | |||||
| Asian | 1.15 | 1.04 | 1.28 | 0.0092* | Race: per patient, 6 levels: White (reference), Asian, Black, Hispanic, multirace/other, unknown |
| Black | 1.10 | 1.05 | 1.15 | <0.0001* | |
| Hispanic | 0.91 | 0.85 | 0.98 | 0.0088* | |
| Multi/other | 0.97 | 0.92 | 1.02 | 0.2722 | |
| Unknown | 1.54 | 1.46 | 1.62 | <0.0001* | |
| Insurance type | |||||
| Dual Medicare and Medicaid | 0.72 | 0.68 | 0.76 | <0.0001* | Insurance: per patient, 8 levels: dual Medicare/Medicaid, Medicaid, Medicare advantage, Medicare fee-for-Service, military, other government, unknown, private (reference) |
| Medicaid | 1.01 | 0.92 | 1.11 | 0.8087 | |
| Medicare advantage | 0.82 | 0.77 | 0.86 | <0.0001* | |
| Medicare FFS | 0.77 | 0.74 | 0.80 | <0.0001* | |
| Military | 1.28 | 1.10 | 1.49 | 0.0016* | |
| Other Government | 1.31 | 0.96 | 1.79 | 0.0864 | |
| Unknown | 1.13 | 1.07 | 1.19 | <0.0001* | |
| No. glaucoma medications | 0.96 | 0.95 | 0.97 | <0.0001* | |
| Mean baseline IOP | 1.01 | 1.01 | 1.01 | <0.0001* | |
| Mean baseline VA | 1.18 | 1.13 | 1.24 | <0.0001* | |
| Provider status | |||||
| Group 2 | 1.10 | 1.05 | 1.14 | <0.0001* | Provider status: per patient eye, 3 levels: group 1 (glaucoma surgeon) (reference), group 2 (other anterior segment surgeon), or group 3 (unknown) |
| Group 3 | 1.25 | 1.20 | 1.31 | <0.0001* | |
| No provider information | 0.72 | 0.60 | 0.88 | 0.001* | |
| Prior glaucoma procedures | |||||
| Yes | 1.03 | 0.92 | 1.14 | 0.6224 | |
| Prior lens surgery | |||||
| Yes | 1.28 | 1.21 | 1.36 | <0.0001* | |
| Prior intravitreal injections | |||||
| Yes | 1.05 | 0.96 | 1.16 | 0.2983 | |
| Diabetes | |||||
| Yes | 1.07 | 1.03 | 1.11 | 0.0003* | |
| Hypertension | |||||
| Yes | 0.93 | 0.85 | 1.01 | 0.0765 | |
| Angle recession | |||||
| Yes | 0.91 | 0.55 | 1.50 | 0.7104 | |
| Uveitis | |||||
| Yes | 1.30 | 1.10 | 1.52 | 0.0009* | |
| Provider LTP count in preceding year | |||||
| 51-99 | 1.10 | 1.06 | 1.15 | <0.0001* | No. LTP performed by provider in the year preceding treatment date, per patient eye, 4 levels: <50 (reference), 50-99, 100-499, 500+ |
| 100-499 | 1.21 | 1.17 | 1.25 | <0.0001* | |
| 500+ | 1.24 | 1.14 | 1.34 | <0.0001* | |
| Glaucoma type | |||||
| Inflammation/drugs | 1.62 | 1.30 | 2.01 | <0.0001* | Glaucoma type: per patient eye, 6 levels: suspect (reference), POAG, trauma, inflammation, other, unspecified |
| POAG | 1.71 | 1.64 | 1.79 | <0.0001* | |
| Trauma/other eye disorders | 1.59 | 1.32 | 1.93 | <0.0001* | |
| Other glaucoma | 1.10 | 0.80 | 1.50 | 0.5712 | |
| Unspecified glaucoma | 0.66 | 0.61 | 0.70 | <0.0001* | |
| Glaucoma severity | |||||
| Moderate | 0.91 | 0.88 | 0.95 | <0.0001* | Glaucoma Severity: per patient eye, stage closest to LTP date, 6 levels: mild (reference), moderate, severe, indeterminate, unspecified/missing, not applicable |
| Severe | 0.89 | 0.85 | 0.94 | <0.0001* | |
| Indeterminate | 1.06 | 0.98 | 1.16 | 0.1557 | |
| Missing/unspecified | 0.37 | 0.35 | 0.39 | <0.0001* | |
| Lens status | |||||
| Aphakia | 0.76 | 0.59 | 0.98 | 0.0339 | Lens status: 4 levels: cataract (reference), pseudophakia, aphakia, unknown |
| Pseudophakia | 0.85 | 0.80 | 0.90 | <0.0001* | |
| Unknown | 0.57 | 0.55 | 0.59 | <0.0001* | |
| LTP treatment group | |||||
| Double | 1.09 | 1.00 | 1.20 | 0.0589 | LTP treatment in 1 session (reference) or in 2 or more session (double) |
All P values are from a multivariable Cox proportional hazards regression.
Statistically significant.
FFS indicates fee-for-service; IOP, intraocular pressure; LTP, laser trabeculoplasty; POAG, primary open angle glaucoma; VA, visual acuity.